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Background: Stroke represents one of the most costly and long-term disabling conditions in adulthood worldwide
and there is a need to determine the effectiveness of rehabilitation programs in the late phase after stroke. Limited
scientific support exists for training incorporating rhythm and music as well as therapeutic riding and well-designed
trials to determine the effectiveness of these treatment modalities are warranted.
Methods/Design: A single blinded three-armed randomized controlled trial is described with the aim to evaluate
whether it is possible to improve the overall health status and functioning of individuals in the late phase of stroke
(1-5 years after stroke) through a rhythm and music-based therapy program or therapeutic riding. About 120
individuals will be consecutively and randomly allocated to one of three groups: (T1) rhythm and music-based
therapy program; (T2) therapeutic riding; or (T3) control group receiving the T1 training program a year later.
Evaluation is conducted prior to and after the 12-week long intervention as well as three and six months later. The
evaluation comprises a comprehensive functional and cognitive assessment (both qualitative and quantitative),
and questionnaires. Based on the International classification of functioning, disability, and health (ICF), the outcome
measures are classified into six comprehensive domains, with participation as the primary outcome measure
assessed by the Stroke Impact Scale (SIS, version 2.0.). The secondary outcome measures are grouped within the
following domains: body function, activity, environmental factors and personal factors. Life satisfaction and health
related quality of life constitute an additional domain.
Current status: A total of 84 participants were randomised and have completed the intervention. Recruitment
proceeds and follow-up is on-going, trial results are expected in early 2014.
Discussion: This study will ascertain whether any of the two intervention programs can improve overall health
status and functioning in the late phase of stroke. A positive outcome would increase the scientific basis for the use
of such interventions in the late phase after stroke.
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Stroke is a multifaceted and complex condition. It is
the second leading cause of death and a major cause
of long-term disability worldwide [1,2], constituting an
enormous cost to the society. Stroke often results in
physical [3-6], cognitive [3,6], psychological [7-15], and
social impairment [13,16,17] and the personal burden of
being a stroke survivor is often devastating and has major
consequences for the patient’s quality of life [18].
Previous research in the field has primarily focused on
treatment in the acute phase and rehabilitation during
the first year after stroke. Experimental animal research
and neuroimaging studies have provided insight into
various aspects of neural plasticity, i.e. possible mechan-
isms of structural and functional neural reorganisation
in the brain following injury [19-21]. The understanding
of the brain’s plastic properties has lead to the emergence
of new approaches in stroke rehabilitation [22]. A num-
ber of animal studies demonstrated that various forms of
multimodal (multisensory) stimulation or an enriched
environment, facilitate multiple processes in the brain
and are associated with improved functional outcome
and neural plasticity [23-33].
There is a growing interest in using music and rhythm
as a stimulus for neurotherapy [34,35]. Music therapy is
the clinical and evidence-based use of music interven-
tions to accomplish individualized goals within a thera-
peutic relationship by professionals who have completed
an approved music therapy program [36]. The new ap-
proach to clinical practice and research, known as
Neurologic Music Therapy (NMT) [37,38] is based on a
neuroscience model of music perception and production,
and the influence of music on functional changes in the
brain and behaviour functions [39]. Using standardized
treatment protocols, NMT is a therapeutic application of
music to cognitive, sensory, and motor dysfunctions due
to neurologic disease of the nervous system [40]. Music
Supported Therapy and Melodic Intonation Therapy
were proposed to induce plastic changes in the brain in
terms of functional connectivity and neural reorganization
in the sensorimotor cortex [41-43], as well as in white
matter tracts [44].
Schneider et al. [45,46] showed that Music Auditory
Stimulation leads to improvements in speed, precision
and smoothness of movements in fine as well as gross
motor skills in stroke patients. Further, music therapy
has a positive effect on mood in patients with stroke
[47-49]. Rhythmic Auditory Stimulation can enhance
gait ability [50-52], flexibility [49], as well as functional
motor performance of the paretic upper extremity [53].
Despite the growing body of scientific evidence in favour
of the use of music therapy in neurorehabilitation, there
is a need for better understanding of the impact of the
therapy programs incorporating music and rhythm.Therapeutic riding (TR), also named Equine-Assisted
Therapy and Adaptive Riding uses equine-assisted activ-
ities for the purpose of contributing positively to cogni-
tive, physical, emotional and social well-being of people
with disabilities [54]. In Sweden, TR is used both in
neurologically disabled adults and children. TR incorpo-
rates mounted activities and exercises, and the patient
actively interacts and influences the horse. The move-
ment of the horse affects the patient both physically and
psychologically. In contrast to hippotherapy [55], defined
as a physical, occupational, and speech-language therapy
treatment strategy that utilizes equine movement as part
of an integrated intervention program to achieve func-
tional outcomes, TR teaches specific skills and techni-
ques associated with riding a horse. The primary focus is
on developing balance, body awareness and muscle tone
in the rider by responding and interacting passively to
the horse’s multidimensional movement. Given the vary-
ing degree of impairment present among stroke survi-
vors, TR has some risks, as do other animal-assisted
therapies. However, in accredited centres these risks are
minimal and the benefits are likely to outweigh them.
There is limited scientific evidence suggesting that TR
is effective. Previous studies indicate that TR and hip-
potherapy are beneficial for improving postural control
in children with cerebral palsy [56-58], patients with
multiple sclerosis [59,60], and spinal cord injuries [61].
A positive effect of hippotherapy associated with con-
ventional physical therapy was shown on gait training in
post-stroke hemiparetic individuals [62]. The ultimate
goals of rehabilitation interventions for stroke survivors
as well as the measurement level selection can be guided
by the International classification of functioning, dis-
ability, and health (ICF) [63-65], namely health-related
domains that are assessed from the body, individual and
societal perspectives: the domain body functions and
structure and the domains of activity and participation.
Functioning is an umbrella term encompassing all of the
domains mentioned above [66], and participation is con-
sidered to be a critically important outcome indicator in
the rehabilitation context [67].
Based on the fundamental principles of brain plasticity,
we developed rhythm and music-based therapy and TR
protocols and designed a three-armed randomized con-
trolled trial to evaluate whether improvement in overall
health status and functioning can be achieved in the
late post stroke phase by using these multimodal therapy
programs. We selected measures most likely to capture
change in the targeted aspects of interventions, linked
them to the ICF model, and hypothesize that both
methods have primary effects on the individuals’ level
of participation. To identify potential biomarkers pre-
dictive of outcome, blood samples taken at several time
points during the study will be analysed. Such biomarkers
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itation programs.
Study aims and objectives
The aim of this study is to investigate whether over-
all health status and functioning can be improved in
community-dwelling individuals in the late phase of
stroke through rhythm and music-based therapy or TR.
The primary aim is to investigate whether improvement
in terms of participation is attained after completion of
these therapy programs. Secondary aims are to investi-
gate whether these two interventions have a positive
effect on body function, activities, environmental and
personal factors, as well as life satisfaction and health
related quality of life in the late phase of stroke. In
addition, using interviews and focus groups as a qualita-
tive research approach, this study aims at understanding
which factors related to the therapies delivered can posi-
tively affect stroke survivors’ lives. We also aim at the




A single blinded three-armed randomized controlled
trial is designed with the aim to evaluate whether it is
possible to improve overall health status and functioning
of individuals in the late phase of stroke (1-5 years after
stroke) through a rhythm and music-based therapy pro-
gram or TR (Trial registration: Clinical Trials.gov Identi-
fier: NCT01372059). The term single blinded refers to
the evaluators in the trial being unaware of the nature
of the treatment the participants are receiving. About
120 individuals will be consecutively and randomly allo-
cated to one of three groups: (T1) rhythm and music-
based therapy program; (T2) TR; or (T3) control group
that receives the T1 therapy a year later. Evaluation is
conducted prior to and after the 12-week long interven-
tion, and three and six months after completed interven-
tion. The evaluation comprises comprehensive functional
and cognitive assessment (both qualitative and quantita-
tive), and questionnaires. Blood samples will be collected
pre-, post intervention and at the three and six month
follow-up with the aim of identifying potential biomar-
kers predictive of outcome. Based on the International
classification of functioning, disability, and health (ICF),
the outcome measures are classified into six compre-
hensive domains, with participation as the primary out-
come measure assessed by the Stroke impact scale (SIS,
version 2.0.). The secondary outcome measures are
grouped within the following domains: body functions,
activity, environmental factors and personal factors. Life
satisfaction and health related quality of life constitute
an additional domain. The trial design is illustrated inFigure 1. Ethical approval was granted by the Regional
Ethical Review Board in Gothenburg (Ref number:
698-09) and the study is conducted in accordance with
relevant ethical guidelines.
Recruitment and selection of participants
The participants are recruited from a comprehensive
hospital-based register covering all patients who were
treated for ischemic or hemorrhagic stroke at Sahlgrenska
University Hospital, Gothenburg, Sweden. The search
criterion is limited to individuals who suffered from
stroke 1 to 5 years prior to their potential inclusion in
the clinical trial. By searching through hospital files, an
authorized research coordinator selects persons poten-
tially eligible for the trial. These individuals are then
contacted through a letter containing information about
the research trial and its implementation. A few days
later, each individual receives a follow-up telephone call
from the research coordinator. The research coordinator
informs the individuals about the study, including
requirements, nature and potential benefits of the two
therapy programs. Consenting interested subjects are
screened by a telephone interview in order to ascertain
eligibility for the trial. Further, we record parameters of
general health (past and current), medication, physical
and cognitive function, stroke-related disability, rehabili-
tation history, history of previous stroke or other diseases
or injuries. Also, information about social relationship,
work situation, living arrangements, and the need for
transportation service for disabled is obtained.
Individuals who have met the study criteria are invited
for a personal appointment with a specialist in rehabili-
tation medicine for a more detailed screening assess-
ment and interview prior to inclusion. A prior history of
stroke is accepted if the previous stroke event affected
the same hemisphere as the most recent stroke. Inclusion
in the trial requires acceptance of allocation and compli-
ance to either of the three treatment arms, even though
allocation to group 3 means that treatment would be
delayed by a year. Participants are informed that they
can withdraw from the study at any time. After the
screening procedure, eligible individuals are included in
the trial. Once included, all participants sign a written
informed consent form. Selection criteria for trial eligi-
bility are presented below:
Inclusion criteria
– Aged 50 − 75 years
– Disability grade 2 or 3 on MRS*)
– Being in the late-phase of stroke (1 − 5 years after
an ischemic or haemorrhagic stroke with initial
presence of hemispheric impact/symptoms)
– Subarachnoid haemorrhage with initial presence of
hemispheric impact/symptoms
Figure 1 Flowchart illustrating trial design. *) Including selected participants.
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and instructions in Swedish
– Having an own housing
– Ability to travel to the place of intervention and
evaluation
– No need for personal assistance in activities of daily
living while participating in the treatment (going to
the toilet, transport/transportation services for
disabled, walking)
– Accepting allocation to either of the three
groups which might mean accepting staying
without any of the treatment procedures for one
yearExclusion criteria
– Disability rated < 2 or > 3 on MRS*)
– An ischemic or haemorrhagic stroke or
subarachnoid haemorrhage without hemispheric
impact/symptoms
– Pronounced fear of horses or allergy constituting a
risk for the patients to participate in the therapeutic
riding
– Heart condition that constitutes a risk for the
individual to participate in the interventions
– Non-controlled epileptic seizures constituting a risk
for the patients to participate in the interventions
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impairment that makes it difficult for the individual
to understand instructions and/or evaluation
– Total paralysis of the affected arm
– Injury or disease that makes the individual not
suitable for the trial
– Weight > 97 kg (to optimize safe horseback riding)
– Having more than a half-time employment
– Injury, disease or addiction that make the individual
not suitable for the trial
– Participation in RGRM or therapeutic riding
intervention < 10 months prior to inclusion
– Having an additional stroke within the past year
(TIA is however accepted)
– Lack of willingness to participate in any of the
treatment methods
– Living > 80 km from Gothenburg
– Dependent on transportation services for disabled
across the community border which is not allowed
according to the regulations
*) Modified Rankin Scale: An ordinal disability rating
scale ranging from zero to 6 (0 = no symptoms). MRS
grade 1: No significant disability despite symptoms; able
to carry out all usual duties and activities; MRS grade 2 =
Slight disability: unable to carry out all previous activities
but able to look after own affairs without assistance;
MRS grade 3 = Moderate disability: requiring some
help, but able to walk without assistance; MRS grade 4:
Moderately severe disability: unable to walk without
assistance and unable to attend to own bodily needs
without assistance; MRS grade 5: Severe disability: bed-
ridden, incontinent and requiring constant nursing care
and attention; MRS grade 6: Dead.
Randomization, allocation concealment and blinding
As gender and laterality might influence outcome in
clinical studies [68], the randomization is stratified with
respect to gender and hemispheric location of the stroke
(right or left hemisphere). Prior to inclusion of parti-
cipants, a statistician performed randomization using
random permuted blocks for each of the 2 × 2
strata. Until the completion of the last long-term follow-
up, only the project leader and two persons responsible
for the interviews and focus groups will have access to the
information on group allocation. Due to the nature of the
therapy programs, blinding of the participants and treating
therapists is not possible. However, all the independent
evaluators are blinded with respect to group allocation,
and the participants are not informed of primary outcome
measure or the study hypothesis. To maintain group allo-
cation confidential, participants are requested prior to
each assessment phase to not reveal allocation or therapy
content to the evaluators. Participants scheduled forqualitative studies are told that they must not talk to the
evaluators about participation in interviews and focus
groups. Furthermore, the interviews and focus groups
are performed in a way that does not reveal participants’
allocation.
Sample size
The calculation of sample size is based on a clinically
relevant difference to be detected across the two main
arms of the trial with an alpha level of 5% and a power
goal of 80%. A Chi-square test was used for statistical
calculations in Nquery 6.0. The required sample size was
determined on the basis of one of the items included in
the primary stroke-specific, comprehensive, health status
outcome measure - Stroke Impact Scale (SIS). SIS mea-
sures the aspects of stroke recovery which were found to
be important to patients and caregivers as well as stroke
experts. The questions of the SIS are broken down into
eight domains: strength, hand function, mobility, activ-
ities of daily living, emotion, memory, communication,
and social participation. The first four of these domains
may be combined into one physical domain, but in order
to more clearly track changes based on the patient’s par-
ticular set of symptoms, the other four items are scored
separately. One additional item is included in the SIS to
assess the subject’s overall perception of recovery. This
item 9 – “Stroke recovery” is presented in the form of a
visual analogue scale from 0 to 100 where 0 indicates
“no recovery” and 100 indicates “full recovery”.
Based on a previous study indicating that the item of
stroke recovery in SIS is a good measure of individual
patient’s changes due to rehabilitation [69], and the het-
erogenic characteristic of the study population, the
required sample size was determined based on this spe-
cific item. The minimal important difference (MID) was
determined a priori. On the basis of previous estimates
[70], MID was set at 10 points of the total range of the
scale in item 9. Thus, a change of 10 points is considered
to represent a meaningful difference. An absolute differ-
ence between the two groups of 30% is defined to be a
clinically meaningful difference with regard to the item
stroke recovery in SIS. Based on this estimate, at least 41
patients would be required in each of the three groups
for the results to satisfy the power criteria of 80%.
Statistical analysis
Outcome variables will be analyzed according to an
intention-to-treat model including all randomized patients
for whom a baseline value exists in the primary outcome
variable. Those who withdraw will be assigned an outcome
score identical to their baseline score i.e. no change. In
addition, the per-protocol analysis will be restricted to the
participants who complete the treatment program and re-
main in the group to which they were randomly assigned,
Figure 2 The RGRM note system with corresponding sound
codes.
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come variables. Patients will be excluded from the per-
protocol analysis if they withdrew during the intervention
phase or undergo a co-intervention during the three-
month intervention phase. Reasons for early withdrawal
will be noted.
Baseline and demographic characteristics will be
summarized using descriptive statistics. Statistical dif-
ference between treatments with respect to the item
“stroke recovery” is to be tested using the chi-square
test (Mantel Haenzel corrected for gender and hemi-
spheric location) by dichotomizing data into categories
improved or unchanged/deteriorated with respect to
change from baseline to follow-up, where improvement/
clinically meaningful change is defined as any increase
equivalent to 10 points of the total range of the scale.
Un-ordered categorical data will be analyzed using the
Mantel Haenzel chi-square approach. Analysis of covari-
ance (ANCOVA) will be used to determine whether there
are any differences between the control and intervention
groups in post-intervention evaluation scores for con-
tinuous data, with baseline scores used as covariates in
the analysis, and gender, hemispheric location and inter-
vention as fixed factors. Qualitative data from the inter-
views and focus groups will be analyzed using content
analysis as described by Malterud [71]. Unsupervised
algorithms will be used to analyze the plasma profiles in
search for predictive biomarkers and biomarker patterns
predictive of therapeutic success. For the primary and
secondary analyses, missing data will be replaced using a
conservative method, i.e. last observation carried forward
(LOCF). All tests will be two-sided and with p<0.05 as a
level of significance.
Interventions
According to consort and trend guidelines for inter-
vention reporting [72], the rationale for the intervention
selection as well as the specification of how the qualities
and delivery of the therapeutic modalities are expected
to impact targeted outcomes are presented below. The
therapeutic modalities used share many therapeutic goals
and similarities in the way they combine information
from different sensory modalities aiming at enhancing
various brain functions. However, due to the way the
methods are organized they differ somewhat in terms of
dosage.
Rhythm and music-based therapy program
We use a method of multi-sensory stimulation of the
brain which is based on rhythm and music and originally
developed by jazz drummer Ronnie Gardiner. The therapy
program, designed to help people with injuries and dis-
eases of the central nervous system [73] is called Ronnie
Gardiner Rhythm and Music method (RGRM™) and hassince 1993 been implemented in health care and rehabili-
tation in Sweden. The method is based on the principle
of neuroplasticity [34], and uses rhythm, music, colour,
the voice, text, shapes and movement to stimulate coord-
ination, balance, endurance, attention, memory, body
image and social interactions. RGRM™ uses a unique
note system (illustrated in Figure 2) that combines red
and blue body symbols with corresponding sound codes
and body movements. The symbols represent hands and
feet and are displayed on a screen. The colours represent
right and left brain activity, with the right brain (red)
governing the left side of the body, and left brain (blue)
governing the right side of the body. In total, there are
18 specific body movements and participants carry out
the movements by clapping hands, tapping their hands
on their knees and stamping their feet on the floor, with-
out using any other tools than their own bodies.
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ways in order to stimulate different parts of the brain. A
certified RGRM™ practitioner creates a piece of move-
ment coordination (chorescore) and participants coord-
inate the series of movements while saying its name, all
accompanied with rhythm and music. Through the
stimulation of senses and the rhythmic activation of body
movements and accompanying sound codes (derived from
drum sounds), the right- and left-hand sides of the body
are activated simultaneously, together with the stimula-
tion of the left- and right brain hemispheres. The level of
difficulty is adjusted with regard to the level of mobility
and capabilities of the participants. At their individual
pace the participants perform increasingly more complex
sequences of rhythmic composite movements. If a par-
ticipant cannot perform a certain movement the person
is instructed to initiate/imagine the movement. The fol-
lowing parameters were selected as the intervention in
the group T1 and T3: two sessions per week for twelve
weeks, each session of 90 min in duration broken into
10 segments including a coffee break and concluded by
a summary.
Therapeutic riding
TR is s multi-sensory treatment modality that combines
physical activity with cognitive stimulation and emo-
tional connection with the horse. Its goal is to improve
posture, balance, coordination, muscular strength and
cognitive functions, while offering an opportunity to
improve motivation and self-esteem. The rhythmic and re-
petitive walking motion of a horse resembles the human
walking gait, and the many textures, sounds and sights
provide an enriched environment. We selected the fol-
lowing parameters as the intervention in the group T2:
two sessions per week for twelve weeks, each session of
240 minutes in duration consisting of two segments,
interaction with the horse prior to or after riding, and
the riding itself. The treatment also includes preparation
of the horse (grooming and equipping the horse with
shabrack, voltage girth and bridle before the riding
session, or their removal afterwards). The sessions are
concluded by eating lunch or having refreshments to-
gether with the therapists and assisting personnel.
The TR is performed at a riding centre adapted for dis-
abled and the riding sessions are held mostly outside in
the paddock and inside during bad weather conditions.
The sessions take place in groups of two to six partici-
pants who ride in pairs for 30 minutes, while the others
are bystanders. The treatment plan as well as appropriate
horses, equipment and exercises are selected in order to
facilitate treatment goals, and to provide the most effect-
ive treatment for each patient along the intervention
period. The sessions are led by a physiotherapist and an
occupational therapist who both have strong equinebackground, as well as knowledge of disabilities related
to stroke and education in TR.
Two assistants prepare the horses and lead them
during the riding sessions and assist during the mounting
on a ramp and the dismounting on the ground. During
riding the participant sits on a shabrack (thick soft cover)
and as a safety precaution, one assistant walks alongside
the horse and another assistant leads the horse. Each
riding session begins and ends with relaxation and body
awareness exercises – deep, slow breathing, focusing and
relaxing body parts starting out from shoulders towards
feet, partly with the eyes shut while instructed to feel
the horse’s movements through their own body. The
mounted exercises are individually tailored to the sub-
jects’ physical needs and ability to ride and include the
following: 1. Balance exercises: maintaining balance while
holding one or both arms sideways; putting the hand/
hands on the head; riding in diagonals, circles, over low
poles and weaving through cones; 2. Trunk rotation:
reaching for the horse’s tail; holding a stick with both
hands with elbows at the waist and then rotating the
trunk to the sides; 3. Exercises designed to train partici-
pants’ affected body parts: simulating bicycling with the
legs; reaching for the horse’s ears; lying prone with the
arms around the horse’s neck and then rising again;
grasping a tennis ball from the instructor in different
directions; controlling the horse by holding the reins;
4. A cognitive component: taking part in the planning
of the participant’s own riding in different directions
and exercises; paying attention to the other equipage in
the paddock while riding; following multiple oral instruc-
tions. Whenever the horse moves or when changes in
speed or direction take place, postural adjustment is
required. All exercises are, if possible, performed while
the horse is moving and mostly the subjects ride at a
walking pace although some participants try a few laps
of trot.
Evaluation procedure
At baseline, group equality will be determined regarding
all descriptive and baseline variables.
The effects of the interventions are evaluated using a
pre- and post-test design. The baseline evaluation phase
precedes randomization and takes place 1−3 weeks prior
to the first intervention session. The post-intervention
evaluation is undertaken within 1−3 weeks and approxi-
mately six month after intervention completion, com-
prising the whole measurement battery. At three months
after completion of the intervention phase, all study
questionnaires are completed and blood samples are col-
lected. A research coordinator, a nurse, a physiotherapist
and a neuropsychologist perform the evaluation of parti-
cipants throughout the trial. At all evaluation phases,
measurements are being carried out in the same sequence




Physiological functions of body systems including
psychological. Structures are anatomical parts or
regions of their bodies and their components.
Impairments are problems in body function or
structure.
Activity The execution of a task by an individual. Limitations
in activity are defined as difficulties an individual
might experience in completing a given activity.
Participation Involvement of an individual in a life situation.
Restrictions to participation describe difficulties
experienced by the individual in a life situation
or role.
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participants beforehand, in order to have them completed
prior to the appointment with the research coordinator.
In order to ensure that the completion of the question-
naire has been correctly performed, the research coord-
inator goes through the questionnaire together with the
participants by face-to-face interviews. The individual
interviews are performed within four weeks after end of
treatment and the focus groups are conducted six months
after completion of the intervention by two experienced
persons (occupational therapist and speech therapist),
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Figure 3 International classification of functioning, disability and hea
(for abbreviations see Table 2).Measures of participant entry characteristics
The participant characteristics recorded are: gender, age,
time since stroke onset both at entry to the trial and at
each evaluative period (days), the type and site of the
stroke lesion, previous stroke insult(s) in the same hemi-
sphere, level of educational attainment and handedness.
The Modified Rankin Scale (MRS) is used to describe
the degree of disability or dependence in daily activities
among the participants [74]. To describe the level of de-
pendence/independence in personal and instrumental
activities of daily living among the participants, the ADL
Staircase is used [75], [76]. The National Institutes
Health Stroke Scales (NHISS) are used to describe neuro-
logical deficit among the participants [75,77].
Outcome measures
Reliable and valid measures are used for the outcome
assessment and are classified according to the different
domains of the ICF [66,78,79]. The ICF definitions are
presented in Table 1. The outcome measures describe
overall health status and functioning at six different
perspectives: 1. Body functions: including the following
subcategories: perceived physical and mental functioning
and cognitive function; 2. Activities; 3. Participation;
4. Environmental factors; 5. Personal factors and 6. Life
satisfaction and quality of life (not part of the ICF).
The outcome measures used within each domain are





mental factors Personal factors
Socio-demographic data
Life satisfaction and health 








lth (ICF) categorization of measures used in the present trial
Table 2 Outcome measure abbreviations
Abbreviation Outcome measure
ADL Activities of Daily Living
ARAT Action Reach Arm Test
BBS Bergs Balance Test
BBL BS Bäckstrand, Dahlberg, and Liljenäs Balance Scale
BBT Box and Blocks Test
BNIS Barrow Neurological Institute Screen for
Higher Cerebral Functions
EQ-5D EuroQol 5D
FIS Fatigue Impact Scale
FES Falls-Efficacy Scale
GSES General Self-Efficacy Scale
LISS Life Situation among spouses after the Stroke
event questionnaire
Lisat-9 Life Satisfaction Checklist-9
MADRS-S Montgomery-Åsberg Depression Rating
Scale – Self rate
M-MAS UAS Modified Motor Assessment Scale according to
the Uppsala University hospital
NVLT Non-Verbal Learning Test
Ruff 2 & 7 SAT Ruff 2 & 7 Selective Attention Test
SIS Stroke Impact Scale
SOC Sense of Coherence
TAP Test for Attentional Performance
TUG Timed Up and Go
VAS Visual Analogue Scale
WAIS Wechsler Adult Intelligence Scale
6MWT 6 Minutes Walk Test
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outcome measures sum scores are calculated when
appropriate.Primary outcome measure
Participation
The main primary outcome is the stroke-specific, self-
report, health status measure Stroke Impact Scale (SIS,
version 2.0) which assesses several dimensions of health
related quality of life: emotion, communication, memory
and thinking, and social role function. The SIS also
includes a question to assess the individual’s global per-
ception of degree of recovery from stroke, with 0 indicat-
ing “no recovery” and 100 indicating “full recovery” and
is used both in clinical and research settings [80]. In the
present study, any increase equivalent to 10% of the
total range of the scale is considered as an improvement.
For the participation domain, the psychosocial subscale
(20 items) of the Fatigue Impact Scale (FIS) is used [81].Secondary outcome measures
Body function and structure
As a measure of perceived physical functioning, the
physical subscale (10 items) of the FIS [80] and the
Montgomery-Åsberg Depression Rating Scale – self rate
(MADRS-S) are used [82,83]. As a measure of perceived
mental functioning, the cognitive subscale (10 items) of
the FIS is used [81]. The participants’ ability to cope with
stress is assessed using the 13-item version of The Sense
of Coherence (SOC) scale [84]. Assessment of general
cognitive level is done using the BNI Screen for Higher
Cerebral Functions (BNIS) [85]. Psychomotor speed and
selective attention are assessed using the Ruff 2 & 7
Selective Attention Test [86]. Psychomotor processing
speed is also assessed by the Symbol search, a subtest
from the Wechsler Adult Intelligence Scale (WAIS-III)
[87]. Working memory is assessed using the Letter-
Number Sequencing (LNS) in Wechsler Adult Intelligence
Scale (WAIS-III) [88] and by a modified shorter version
of the subtest Digit span in (WAIS-III). Alertness, simple
psychomotor speed and working memory is assessed
using the computerized Test for Attentional Performance
(TAP) [89]. Non-verbal learning of visual patterns is eval-
uated by the Non-verbal Learning Test (NVLT) included
in the computerized Vienna Test System [90]. After the
performance of the above listed cognitive tests, the parti-
cipants rate their experienced mental and physical fatigue
using a Visual Analogue Scale (VAS) [91]. Grip strength
is measured using a GrippitW instrument (AB Detektor,
Göteborg, Sweden) [92].
Activity
Self-belief to cope with a variety of difficult demands
in life is assessed using the General Self-Efficacy Scale
(GSES) [93]. As a measure of perceived physical func-
tioning, the physical subscale of the FIS (10 items) is used
[80]. Perceived confidence in task performance is mea-
sured using Swedish modification of the Falls-Efficacy
Scale – FES (S) [94]. Balance is evaluated by the Berg
Balance Scale (BBS) [95]. Even though there are no for-
mal validity or reliability data published yet, the Swedish
clinical observer-assessed Bäckstrand, Dahlberg, and
Liljenäs Balance Scale (BDL BS) is used as a comple-
ment to BBS in order to detect changes in individuals
with light to moderate balance disturbances [96,97]. The
BDL BS is translated into English [98]. Motor recovery is
assessed using the Modified Motor Assessment Scale
according to the Uppsala University hospital (M-MAS
UAS) [99]. Walking capacity is measured using the
6-minute walk test (6MWT) [100]. Mobility is measured
by the Timed “up and Go” (TUG) test [101]. Upper limb
function is determined using the Action Research Arm
Test (ARAT) [102]. Manual dexterity is measured using
the Box and Block Test (BBT) [103] and manual ability
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level of dependence/independence in personal and in-
strumental activities of daily living among the partici-
pants is evaluated by the Activities of Daily Living (ADL)
staircase [75].
Environmental factors
The life situation of spouses is evaluated by the Life Situ-
ation among Spouses after the stroke event questionnaire
(LISS) [105].
Life satisfaction and health related quality of life
Life satisfaction is measured using the Life Satisfaction
Checklist - LiSat-9 [106]. Health-related quality of life is
measured using the EuroQol (EQ-5D) [107,108].Qualitative outcome measures
Both individual interview and focus groups methodology
are used. Selected participants from each intervention
group are interviewed when treatment is finalized in
order to study their experiences from the two interven-
tions and how they impact on their life situation. As a
complement to individual interviews, focus groups are
conducted six months after end of treatment to facilitate
the opportunity for selected participants to interact
during a group discussion based on experiences from the
interventions and the subsequent impact on life satisfac-
tion and performance in daily life. Both interviewers are
present at the focus groups in which the occupational
therapist has the main responsibility for probing questions
using a semi-structured interview guide. The speech ther-
apist assists aphasic participants in the discussion.
The participants’ expectation of the treatment is mea-
sured using a self-constructed questionnaire containing
the following two questions; 1. How effective do you be-
lieve the treatment is for individuals with a history of
stroke? with four possible answers ranging from “very
effective” to “not effective”, and; 2. What impact do you
believe the treatment has on the difficulties you have
following your stroke? with four possible answers ranging
from “huge impact” to “no impact”.Blood sampling and analysis
Blood samples are taken for the analysis of biomarkers.
The participants come fasting and the blood is drawn
between 8.00 and 10.00 a.m. At all four evaluation periods
blood samples are taken from each participant and serum
and EDTA plasma are prepared and stored in aliquots
at -70°C for use for biochemical analysis, proteomic and
quantitative real time PCR. Further, buffy coat obtained
from EDTA blood is aliquoted and either frozen directly
or frozen in a cryoprotectant at -140°C in order to get
individual cells intact for quantitative single cell rtPCR.In addition, blood drawn into a PAXgene tube will serve
for whole blood preparation for mRNA preparation
and gene expression profiling. After being in room
temperature for at least 4 hours these samples are frozen
at -20°C for 24 hours and then at -80°C. Depending on
the clinical outcome, mRNA will be prepared from
samples from selected participants.
Protein presence is detected and the relative quantity
of individual proteins in blood plasma is measured using
relative quantification with mass spectrometry and iso-
baric tagging reagents that yield amine derived peptides
for quantification [109,110]. The quantitative proteomics
analysis will provide information about relative protein
ratios in selected patients before and after intervention.
This explorative part of the study is aimed to form a basis
for later validation of possible candidate biomarkers.
Current status
A total of 84 participants were randomised and have com-
pleted the intervention and the recruitment is expected to
be completed by August 2013. The drop-out rate in the
study has been 7%, including one participant allocated to
T3 who suffered a new stroke, and another participant ran-
domized to group T3, who deceased during the treatment
period. Two of the drop-outs were randomized to group
T3 and one was allocated to group T2. Recruitment pro-
ceeds and follow-up is on-going, trial results are expected
in 2014.
Discussion
Stroke represents one of the most costly and long-term dis-
abling conditions in adulthood worldwide and there is a
need to determine the effectiveness of rehabilitation pro-
grams in the late phase after stroke for which currently only
limited scientific support exists. The general belief has been
that treatment of individuals in the late phase of stroke is of
no benefit. Today, the concept of brain plasticity gives hope
for improvements in rehabilitation that go beyond spontan-
eous recovery of function [111]. The rehabilitation process
should encompass all dimensions of a stroke survivor’s life,
and rehabilitation programs that address both the social
and physical needs of the patients, preferably individually
tailored, are therefore highly desirable.
The present study was structured and designed according
to CONSORT guidelines [112], in order to enable its
reproduction in both clinical and research settings. The ra-
tionale for the study derives from the fact that various
forms of enriched environments and multimodal stimula-
tion components have positive influence on motivation and
psychosocial well-being and facilitate multiple processes in
the brain, leading to structural regeneration and functional
recovery [23-33].
The results of the trial may contribute to the knowledge
about the effects of rhythm and music-based therapy and
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status and functioning, and might also help to identify the
predictive parameters of therapeutic success. We anticipate
that the results will have important implications for health
care policy by increasing the scientific basis for such inter-
ventions and contribute to the implementation of effective
rehabilitation programs in the clinical praxis.
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